Overview
Updated 14 Jul 2026
Lisa H. Lancaster, MD, is Chief Medical Officer, Endeavor BioMedicines. The public record shows 196 publications with 17,874 citations (h-index 51), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Pulmonary Hypertension Research and Treatments. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 17 companies, 1 NIH-funded awards (2007–2008).
- Most recent indexed publication: 2022 · Advances in therapy
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 90.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
Sponsor: Endeavor Biomedicines, Inc.
InvestigatorPhase 1RecruitingNCT07454291 - A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Sponsor: Endeavor Biomedicines, Inc.
InvestigatorPhase 2Active, not recruitingNCT06422884 - A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Sponsor: Endeavor Biomedicines, Inc.
InvestigatorPhase 2CompletedNCT05199584
Industry payments
Updated 14 Jul 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year202520 payments$14,840openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- United Therapeutics CorporationProgram year20251 payment
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2007–2008 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.
Advances in therapy
2022 - Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis.
The open respiratory medicine journal
2020 - Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.
BMJ open respiratory research
2020
Most-cited worksby citation count (OpenAlex)
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vanderbilthealth.com ↗
Editorial & leadership rolesjournal and society appointments
- Steering Committee member
Diffuse Lung Disease Network, American College of Chest Physicians
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endeavorbiomedicines.com ↗ - Steering Committee member
Pulmonary Fibrosis Foundation Registry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endeavorbiomedicines.com ↗
Secondary affiliationsappointments beyond the home institution
- Professor of Medicine (former, transitioned to CMO role at Endeavor BioMedicines April 2025)
Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.vumc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/lisa-lancaster-md-87674e0f
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/lisa-lancaster-6395405
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
discoveries.vanderbilthealth.com/authors/lisa-lancaster-m-d
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →discoveries.vanderbilthealth.com ↗ - Other
endeavorbiomedicines.com/endeavor-biomedicines-appoints-internationally-renowned-ild-expert-lisa-lancaster-m-d-as-chief-medical-officer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endeavorbiomedicines.com ↗ - Other
pulmonaryfibrosis.org/about-us/who-we-are/medical-advisory-committees/medical-advisory-board
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.